Who
Victor J. Dzau
Director
Company insider
Files Form 4 as: Director, United Therapeutics; Director, Medtronic; Director, PepsiCo; Director, Alnylam Pharmaceuticals; Director, Genzyme.
In numbers
- Trades disclosed
- 129
- Buys
- 2
- Sells
- 3
- Bought
- $155K
- Sold
- $1.8M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 25 May 2006
- Last trade
- 22 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —730 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,300 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —730 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,300 at $0.00 | filing |
| 30 Jun 2014filed 2 Jul 2014 | Medtronic | SEC FORM 4 Code A | —399 at $0.00 | filing |
| 28 Apr 2014filed 30 Apr 2014 | Medtronic | SEC FORM 4 Code A | —2,384 at $0.00 | filing |
| 2 Dec 2013filed 4 Dec 2013 | PEP PepsiCoBeverages | SEC FORM 4 Code A | $50K597.37 at $83.70 | filing |
| 1 Oct 2013filed 3 Oct 2013 | PEP PepsiCoBeverages | SEC FORM 4 Code A | —1,879.23 at $0.00 | filing |
| 30 Sep 2013filed 3 Oct 2013 | PEP PepsiCoBeverages | SEC FORM 4 Code A | —724.55 | filing |
| 6 Jun 2013filed 10 Jun 2013 | ALNY Alnylam Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 29 Apr 2013filed 1 May 2013 | Medtronic | SEC FORM 4 Code A | —2,989 at $0.00 | filing |
| 1 Oct 2012filed 3 Oct 2012 | PEP PepsiCoBeverages | SEC FORM 4 Code A | $67K943.62 at $70.65 | filing |
| 1 Oct 2012filed 3 Oct 2012 | PEP PepsiCoBeverages | SEC FORM 4 Code A | —2,123.14 at $0.00 | filing |
| 28 Sep 2012filed 3 Oct 2012 | PEP PepsiCoBeverages | SEC FORM 4 Code A | —674.81 | filing |
| 21 Jun 2012filed 25 Jun 2012 | ALNY Alnylam Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 30 Apr 2012filed 2 May 2012 | Medtronic | SEC FORM 4 Code A | —3,665 at $0.00 | filing |
| 1 Oct 2011filed 5 Oct 2011 | PEP PepsiCoBeverages | SEC FORM 4 Code A | —2,487.97 at $0.00 | filing |
| 30 Sep 2011filed 5 Oct 2011 | PEP PepsiCoBeverages | SEC FORM 4 Code A | —607.16 | filing |
| 9 Jun 2011filed 13 Jun 2011 | ALNY Alnylam Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 2 May 2011filed 4 May 2011 | Medtronic | SEC FORM 4 Code A | —3,305 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.